Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 543 | 455 | 100 | 69 | 38 |
| Gross Profit | 543 | 455 | 100 | 69 | 38 |
| Operating Expenses | 4,430 | 3,997 | 2,565 | 1,686 | 1,846 |
| Operating Income | -3,887 | -3,542 | -2,465 | -1,617 | -1,808 |
| Other Income | 93 | 77 | 43 | 35 | 43 |
| Pre-tax Income | -3,794 | -3,465 | -2,422 | -1,582 | -1,765 |
| Net Income Continuous | -3,794 | -3,465 | -2,422 | -1,582 | -1,765 |
| Net Income Discontinuous | 0 | 33 | 257 | N/A | N/A |
| Net Income | $-3,794 | $-3,432 | $-2,165 | $-1,582 | $-1,765 |
| EPS Basic Total Ops | -10.08 | -10.08 | -6.72 | -4.80 | 17.57 |
| EPS Basic Continuous Ops | -10.08 | -9.60 | -6.72 | -4.32 | -5.76 |
| EPS Basic Discontinuous Ops | 0.87 | 0.09 | 0.48 | -0.48 | 0.96 |
| EPS Diluted Total Ops | -10.08 | -10.08 | -6.72 | -4.80 | 17.57 |
| EPS Diluted Continuous Ops | -10.08 | -9.60 | -6.72 | -4.32 | -5.76 |
| EPS Diluted Discontinuous Ops | 0.87 | 0.09 | 0.48 | -0.48 | 0.96 |
| EBITDA(a) | $-3,734 | $-3,396 | $-2,326 | $-1,483 | $-1,654 |